Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sensorion

< Previous 1 2 3 4 Next >
News headline image
Sensorion Announces a Reverse Share Split of its Shares
From Sensorion
Via Business Wire
News headline image
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
From Sensorion
Via Business Wire
News headline image
Sensorion Appoints Fred Chereau as Chief Executive Officer
From Sensorion
Via Business Wire
News headline image
Sensorion Announces its Participation in the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
From Sensorion
Via Business Wire
News headline image
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 11, 2026
From Sensorion
Via Business Wire
News headline image
Sensorion Reports Six-Month Update from the Audiogene Phase 1/2 Trial of SENS-501 and Advances GJB2-GT (SENS-601) Toward First-in-Human Clinical Development
From Sensorion
Via Business Wire
News headline image
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Leadership Changes
From Sensorion
Via Business Wire
News headline image
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting
From Sensorion
Via Business Wire
News headline image
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
From Sensorion
Via Business Wire
News headline image
Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Sensorion
Via Business Wire
News headline image
Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial
From Sensorion
Via Business Wire
News headline image
Sensorion Reports 2025 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
From Sensorion
Via Business Wire
News headline image
Sensorion Announces an Increase in Resources Allocated to the Liquidity Contract with Kepler Cheuvreux
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Its Participation In Upcoming Investor Conferences
From Sensorion
Via Business Wire
News headline image
Sensorion Completes Patient Enrollment of the Second Cohort in Audiogene Phase 1/2 Gene Therapy Clinical Trial
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Preliminary Positive Data from the First Cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial
From Sensorion
Via Business Wire
News headline image
Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
From Sensorion
Via Business Wire
News headline image
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Presentation by Pr. Natalie Loundon at the 2025 American Society of Pediatric Otolaryngology Annual Meeting
From Sensorion
Via Business Wire
News headline image
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025
From Sensorion
Via Business Wire
News headline image
Sensorion to Host a Symposium during ISIET’s International Conference on Inner Ear Therapies on April 26, 2025
From Sensorion
Via Business Wire
News headline image
Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
From Sensorion
Via Business Wire
News headline image
Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
From Sensorion
Via Business Wire
News headline image
Sensorion Reports Full-Year 2024 Results, Provides Corporate Update and Announces Availability of Full-Year Report
From Sensorion
Via Business Wire
News headline image
Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity
From Sensorion
Via Business Wire
News headline image
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
From Sensorion
Via Business Wire
News headline image
Sensorion Announces Its Participation In Several Congresses To Be Held In March
From Sensorion
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback